ArticleScientific reports2026
Machine learning-driven discovery of STAT1 and TRIM22 as immune biomarkers for lupus nephritis: translational insights into diagnosis and pathogenesis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus and a major cause of renal dysfunction, while reliable non-invasive biomarkers remain limited. Transcriptomic data from three LN cohorts were analyzed to identify differentially expressed genes (DEGs). Immune-associated DEGs were selected using WGCNA and prioritized via multiple machine learning algorithms. Diagnostic performance was evaluated with ROC curves and nomogram modeling, accompanied by functional enrichment and immune infiltration analyses. Independent validation was performed by qRT-PCR in peripheral blood samples from 13 LN patients and 10 healthy controls. A total of 320 DEGs were identified, including 53 linked to immune processes. In the transcriptomic datasets, four candidate hub genes (CD40LG, RETN, TRIM22, STAT1) were initially identified. Furthermore, immune infiltration analysis suggested gene-specific immune interaction patterns, particularly associating TRIM22 with CD4⁺ T-cell–related signatures. qRT-PCR confirmed upregulation of STAT1 and TRIM22, while RETN and CD40LG showed no significant elevation. Accordingly, a refined two-gene signature was constructed, showing consistent discriminatory trends in the training dataset and the clinical validation cohort (AUCs > 0.9). STAT1 and TRIM22 were consistently upregulated in the peripheral blood of patients with lupus nephritis and may represent potential immune-related biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.